Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525510 · ClinicalTrials.gov registry record · NA
Deceased Organ Donor Interventions to Protect Kidney Graft Function
A NA study of Delayed Graft Function and Brain Death, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,427
- Enrollment target
- 7
- Study locations
NCT02525510 is a NA study of Delayed Graft Function and Brain Death that has completed, run by University of California, San Francisco. The registered enrollment target is 1,427 participants, above the 137-participant average among 6 other Delayed Graft Function trials with a reported enrollment target (942% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT02525510, a NA study of Delayed Graft Function and Brain Death, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,427 participants
- Enrollment target
- 7
- Study locations
Study Summary
To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
Conditions Studied
Interventions
- OTHER Pump Eligible - Normothermia - Pump Both Kidneys
- OTHER Pump Eligible - Hypothermia and Pump Right Kidney
- OTHER Pump Eligible - Hypothermia and Pump Left Kidney
- OTHER Not Pump Eligible - Normothermia
- OTHER Not Pump Eligible - Hypothermia
Study Locations (7)
Texas
- Southwest Transplant Alliance - Dallas
- LifeGift - Houston
Arizona
- Donor Network of Arizona - Phoenix
California
- U C San Francisco - San Francisco
Colorado
- Donor Alliance - Denver
Minnesota
- LifeSource - Minneapolis
Oregon
- Pacific Northwest Transplant Bank - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,427 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02525510
The ClinicalTrials.gov registry entry for NCT02525510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,427 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 137-participant average among 6 other Delayed Graft Function trials with a reported enrollment target (942% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Delayed Graft Function appearing as the primary indexed condition, and to 5 interventions - of which Pump Eligible - Normothermia - Pump Both Kidneys is the first listed.
NCT02525510 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Texas, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT02525510 about?
NCT02525510 is a clinical study titled "Deceased Organ Donor Interventions to Protect Kidney Graft Function". To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
What is the current status of trial NCT02525510?
This trial is currently completed. It is a NA study. The enrollment target is 1,427 participants. The study started on 2017-07-26. Estimated completion is 2022-06-01.
What conditions does trial NCT02525510 study?
This clinical trial studies the following conditions: Delayed Graft Function, Brain Death, Organ Donation, Organ Transplant Failure or Rejection.
What interventions are being tested in trial NCT02525510?
The interventions under investigation include: Pump Eligible - Normothermia - Pump Both Kidneys (OTHER), Pump Eligible - Hypothermia and Pump Right Kidney (OTHER), Pump Eligible - Hypothermia and Pump Left Kidney (OTHER), Not Pump Eligible - Normothermia (OTHER), Not Pump Eligible - Hypothermia (OTHER).
Who is sponsoring clinical trial NCT02525510?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02525510 being conducted?
This trial has 7 study locations across Arizona, California, Colorado, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delayed Graft Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
RECRUITING · Phase 1
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
ACTIVE NOT RECRUITING · Phase 2
-
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
COMPLETED · Phase 1
-
Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
COMPLETED · Phase 4
-
Envarsus in Delayed Graft Function (E-DGF)
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.